Scale -

  • Revenue is 944 Rs Cr; Annual Growth is 15 %; Continuous Growth over 3 years; in Top Quartile
  • PBT is 30.04 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is -13 %
  • Quarterly Revenue is 261 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Profit is 22.31 Rs Cr; Continuous Growth over 3 Quarters
  • Quarterly Ebitda is 46.61 Rs Cr; in Top Quartile
  • PAT is 64.21 Rs Cr; Continuous Decline over 3 years; 5 Year CAGR is -14 %

Profitability -

  • PAT Margin is 6.8 %; Annual Decline is -20 %; Continuous Decline over 3 years; 5 Year CAGR is -20 %
  • PBDIT Margin is 16.31 %; Continuous Decline over 3 years

Return -

  • Asset Turnover is 75 %; Continuous Growth over 3 years
  • ROCE is 14.93 %; Continuous Decline over 3 years
  • ROA is 4.78 %; Continuous Decline over 3 years; 5 Year CAGR is -22 %
  • ROE is 9.65 %; Continuous Decline over 3 years; 5 Year CAGR is -23 %

Efficiency -

  • Operating cash flow is 45.14 Rs Cr; Annual Decline is -63 %
  • Quick Ratio is 0.92; Continuous Decline over 3 years

Solvancy -

  • Long term Debt is 105 Rs Cr; Continuous Decline over 3 years; in Top Quartile
  • Contingent Liabilities is 11.7 Rs Cr; Annual Growth is 70 %
  • Debt/Equity is 0.58; in Top Quartile
  • Total Debt is 385 Rs Cr; in Top Quartile

Quality -

  • Current Tax/PAT is 21 %; Annual Decline is -21 %; Continuous Decline over 3 years; 5 Year CAGR is -20 %
  • Change in Inventories/Total Expenses is -8 %; Annual Decline is -135 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/ebitda is 29 %; Annual Decline is -67 %; in Bottom Quartile
  • Operating cashflow/PAT is 70 %; Annual Decline is -60 %
  • Other Expenses/Total Expenses is 25 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Gufic Biosciences Limited Receives Three Observations from USFDA for Indore Manufacturing Facility
Read More
  • Past/current